Detalhe da pesquisa
1.
Comparison of drug prescribing before and during the COVID-19 pandemic: A cross-national European study.
Pharmacoepidemiol Drug Saf
; 31(10): 1046-1055, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35791700
2.
Utilization of cardiovascular medicines and cardiovascular mortality in Lithuania, Sweden and Norway in 2003-2012.
Medicina (Kaunas)
; 53(4): 259-267, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28844562
3.
Personalizing health care: feasibility and future implications.
BMC Med
; 11: 179, 2013 Aug 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-23941275
4.
Corrigendum to "Utilisation Trend of Long-Acting Insulin Analogues including Biosimilars across Europe: Findings and Implications".
Biomed Res Int
; 2023: 9757348, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37065720
5.
Reimbursed Medication Adherence Enhancing Interventions in European Countries: Results of the EUREcA Study.
Front Pharmacol
; 13: 892240, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35784711
6.
Reimbursed medication adherence enhancing interventions in 12 european countries: Current state of the art and future challenges.
Front Pharmacol
; 13: 944829, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36034792
7.
Utilisation Trend of Long-Acting Insulin Analogues including Biosimilars across Europe: Findings and Implications.
Biomed Res Int
; 2021: 9996193, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34676266
8.
Risk sharing arrangements for pharmaceuticals: potential considerations and recommendations for European payers.
BMC Health Serv Res
; 10: 153, 2010 Jun 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-20529296
9.
Antibiotic prescribing trends in a pediatric population in Lithuania in 2003-2012: Observational study.
Medicine (Baltimore)
; 98(46): e17220, 2019 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-31725600
10.
Pharmacotherapeutic interventions for bipolar disorder type II: addressing multiple symptoms and approaches with a particular emphasis on strategies in lower and middle-income countries.
Expert Opin Pharmacother
; 20(18): 2237-2255, 2019 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-31762343
11.
International trends in antipsychotic use: A study in 16 countries, 2005-2014.
Eur Neuropsychopharmacol
; 27(10): 1064-1076, 2017 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28755801
12.
Payers' Views of the Changes Arising through the Possible Adoption of Adaptive Pathways.
Front Pharmacol
; 7: 305, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27733828
13.
Are new models needed to optimize the utilization of new medicines to sustain healthcare systems?
Expert Rev Clin Pharmacol
; 8(1): 77-94, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25487078
14.
Multiple policies to enhance prescribing efficiency for established medicines in Europe with a particular focus on demand-side measures: findings and future implications.
Front Pharmacol
; 5: 106, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24987370
15.
Dabigatran - a continuing exemplar case history demonstrating the need for comprehensive models to optimize the utilization of new drugs.
Front Pharmacol
; 5: 109, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24959145
16.
Dabigatran - a case history demonstrating the need for comprehensive approaches to optimize the use of new drugs.
Front Pharmacol
; 4: 39, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23717279
17.
Differences in utilization rates between commercial and administrative databases: implications for future health-economic and cross-national studies.
Expert Rev Pharmacoecon Outcomes Res
; 16(2): 149-52, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-26914489
18.
European countries with small populations can obtain low prices for drugs: Lithuania as a case history.
Expert Rev Pharmacoecon Outcomes Res
; 11(3): 343-9, 2011 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-21671703
19.
Use of Generics-A Critical Cost Containment Measure for All Healthcare Professionals in Europe?
Pharmaceuticals (Basel)
; 3(8): 2470-2494, 2010 Aug 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-27713363
20.
Comparing policies to enhance prescribing efficiency in Europe through increasing generic utilization: changes seen and global implications.
Expert Rev Pharmacoecon Outcomes Res
; 10(6): 707-22, 2010 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-21155704